Evidence map›Paper›PMID 29799076›Full record

ArticleCancer immunology, immunotherapy : CII2018

T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin.

Corinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, Jochen Utikal, Petra Boukamp, Hellmut G Augustin, Sergij Goerdt, Cyrill Géraud, Moritz Felcht

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.International journal of molecular sciences · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Corinne BauerDepartment of Dermatology, Venereology and Allergy, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University and Centre of Excellence of Dermatology of Baden-Württemberg, Mannheim, Germany.
Ashik Ahmed Abdul PariEuropean Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Viktor UmanskyDepartment of Dermatology, Venereology and Allergy, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University and Centre of Excellence of Dermatology of Baden-Württemberg, Mannheim, Germany.
Jochen UtikalDepartment of Dermatology, Venereology and Allergy, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University and Centre of Excellence of Dermatology of Baden-Württemberg, Mannheim, Germany.
Petra BoukampGenetics of Skin Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hellmut G AugustinEuropean Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Sergij GoerdtDepartment of Dermatology, Venereology and Allergy, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University and Centre of Excellence of Dermatology of Baden-Württemberg, Mannheim, Germany.
Cyrill GéraudDepartment of Dermatology, Venereology and Allergy, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University and Centre of Excellence of Dermatology of Baden-Württemberg, Mannheim, Germany.
Moritz FelchtDepartment of Dermatology, Venereology and Allergy, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University and Centre of Excellence of Dermatology of Baden-Württemberg, Mannheim, Germany. moritz.felcht@umm.de.
University Hospital Heidelberg · DEHeidelberg University · DEDKFZ-ZMBH Alliance · DEUniversity Medical Centre Mannheim · DE

Funding

Bundesministerium für Bildung und Forschung (DE) FKZ 02NUK036ADeutsche Forschungsgemeinschaft (DE) FE 1282/2-1Deutsche Forschungsgemeinschaft (DE) GRK2099/RTG2099
6 · The paper itself

Abstract

backgroundT-lymphocytes are involved in tumor progression and regression. Actinic keratoses (AK) are atypical proliferations of keratinocytes of the skin. Some AK progress into invasive cutaneous squamous cell carcinomas (cSCC). Keratoacanthomas (KA) are either classified as a cSCC subtype or a benign tumor with histologic resemblance to well-differentiated cSCC as it is supposed to regress spontaneously. In contrast, cSCC represent malignant tumors that may metastasize.

objectivesTo compare the T-lymphocyte profiles of AK, KA and cSCC in relation to PD-L1 expression.

methodsTissue micro-arrays of 103 cases of AK, 43 cases of KA and 106 cases of cSCC were stained by immunohistochemistry for E-cadherin, CD3, CD4, CD8, FOXp3, and the receptor-ligand pair PD-1/PD-L1. Immunohistological scores were computationally determined to assess PD-L1 expression as well as the expression profiles of T-lymphocytes.

resultsAK had lower numbers of CD3+ and PD-1+ cells compared to KA and lower numbers of CD3+, CD8+ and PD-1+ cells in comparison with cSCC. KA showed significantly higher numbers of CD4+ and FOXp3+ cells as well as lower numbers of CD8+ cells in comparison with invasive cSCC. cSCC expressed significantly more PD-L1 in comparison with AK and KA. Among cSCC PD-L1 expression was higher in moderately and poorly-differentiated cSCC than in well-differentiated cSCC. Increased PD-L1 expression also correlated with increased numbers of CD4+, CD8+ and FOXp3+ cells in cSCC.

conclusionsTumor-associated T-lymphocyte infiltrates showed significant differences between AK, KA and invasive cSCC. PD-L1 expression correlated with invasion of T-cell infiltrates in invasive cSCC.

Indexed as

AgedAged, 80 and overB7-H1 AntigenBiomarkers, TumorCarcinoma, Squamous CellCase-Control StudiesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleFollow-Up StudiesHumansKeratoacanthomaLymphocytes, Tumor-InfiltratingMaleMiddle AgedNeoplasm InvasivenessB7-H1 AntigenBiomarkers, TumorCD274 protein, humanFOXp3PD-1PD-L1Tumor microenvironment

Identifiers

PMID29799076
PMCPMC11028118
OpenAlexW2804160523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.